EmVenio Insights
Explore our resources, including blogs, whitepapers, press, videos, and more.
Webinar Recap: “Standardizing Scalable and Compliant Technology for Hybrid Trials”
October 29, 2024 | Webinar
The Society for Clinical Research Sites recently hosted a webinar featuring EmVenio and RealTime eClinical Solutions about “Standardizing Scalable and Compliant Technology for Hybrid Trials,” which discussed the role technology plays in hybrid clinical trials. Phillip Stanford, EmVenio’s senior director…
EmVenio connects with local residents at Reflections Atlanta art event
October 21, 2024 | Blog
At EmVenio, we believe community intervention is the first step to creating inclusivity and trust in clinical research. This month, we had the privilege of meeting community members of the Greater Atlanta area at “Reflections Atlanta: Illuminating Diversity in Medicine…
EmVenio team at SCRS’s 2024 Global Site Solutions Summit
October 17, 2024 | Blog
EmVenio has been an active member in the Society of Clinical Research Sites since our founding in 2022, and many of our team members have been involved in the SCRS community over the course of their careers. We also recently…
EmVenio celebrates opening of first Prime Healthcare research center
October 16, 2024 | Blog
EmVenio leadership and staff gathered in late September for a ribbon-cutting and open house at one of our first clinical trial research centers within the Prime Healthcare hospital system. This location is inside the Southern Regional Medical Center in Riverdale,…
Webinar: Advancing Clinical Research Through Hybrid Clinical Trials and Patient Optionality
August 20, 2024 | Webinar
Discover an informative webinar that revolutionizes the impact of hybrid clinical trials by implementing patient-centric solutions that fast-track the development of life-changing therapies. Historically, trials necessitated in-person participation, requiring volunteers to travel to research sites. On average, travel times amounted to two hours, excluding the time spent…
The FDA’s timeline: advancing diversity in clinical trials
August 14, 2024 | Blog
The United States Food and Drug Administration has issued several guidances throughout the last five years to enhance the diversity, equity, and inclusivity of clinical trials. These are significant and much-needed additions to the industry, supporting EmVenio’s mission of providing…
EmVenio’s clinical research sites at Prime Healthcare hospitals now open in Dallas and Atlanta
August 1, 2024 | Press Release
Pre-study visits now available for clinical research organizations and trial sponsors DURHAM, N.C., Aug. 1, 2024 /PRNewswire/ — EmVenio Research announced today it has opened two dedicated research centers within the Prime Healthcare hospital system, located in the greater Dallas and Atlanta areas. The sites are currently open…
PCM Trials and EmVenio Research Announce the Appointment of Jeff Huntsman as Chief Commercial Officer
July 23, 2024 | Press Release
Denver, CO., July 23, 2024 – PCM Trials and EmVenio Research, a PCM Trials Company are pleased to announce the addition of Jeff Huntsman to the leadership team as Chief Commercial Officer. Jeff brings over 30 years of experience in commercial planning,…
EmVenio Research Commits to SCRS Global Impact Partner Program
June 6, 2024 | Blog
June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT)…
EmVenio Research’s May 2024 Community Engagement Highlights
May 31, 2024 | Blog
Our collaboration with local organizations creates opportunity to address critical health issues and topics through the lens of clinical research, promoting wellness, and bringing value to the communities we serve. The well-being of our communities remains at the forefront. Together,…
EmVenio Research and Health Wizz partner to reach patients across the US
May 14, 2024 | Press Release
U.S.-based researcher and Health Wizz partner to provide clinical research as a care option DURHAM, N.C., May 14, 2024 – Community research provider EmVenio Research and technology company, Health Wizz are pleased to announce a new partnership to address site…
Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
May 2, 2024 | Press Release
Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile research units, aimed at improving access to trials DEERFIELD, Ill. and RIDGEFIELD, Conn., May 2, 2024 — Walgreens and Boehringer…